News outlets continue coverage of a new study showing a meningitis vaccine remains stable and effective without refrigeration.

IRIN: Meningitis vaccine out of the cold
“A pilot meningitis A immunization campaign targeting more than 155,000 people in Benin with a vaccine that does not require constant refrigeration has demonstrated clear benefits, enabling wider reach, more efficient administration and potential cost reduction, researchers say…” (2/20).

Thomson Reuters Foundation: Benin trial shows vaccine need not be kept cold, can cost less
“Research has shown that a meningitis A vaccine can survive high temperatures for up to four days, and could therefore reach more people in remote areas across the African continent and cost half as much as it does now, a paper in the scientific journal Vaccine reported on Wednesday…” (Hussain, 2/19).